| Citation: | CHANG Dongge, YANG Ning, YUAN Yongmei, TIAN Qi. Establish Nomogram for myocardial damage in emergency sepsis patients based on mitochondrial damage index, and evaluate its predictive efficacy[J]. Chinese Journal of General Practice, 2025, 23(11): 1850-1853. doi: 10.16766/j.cnki.issn.1674-4152.004243 |
| [1] |
FRENCKEN J F, VAN SMEDEN M, VAN DE GROEP K, et al. Etiology of myocardial injury in critically ill patients with sepsis: a cohort study[J]. Ann Am Thorac Soc, 2022, 19(5): 773-780. doi: 10.1513/AnnalsATS.202106-689OC
|
| [2] |
秦苏徽, 顿士娟. 脓毒症相关凝血功能障碍患者发病及预后危险因素分析[J]. 中华全科医学, 2021, 19(12): 2020-2023. doi: 10.16766/j.cnki.issn.1674-4152.002225
QIN S H, DUN S J. Analysis of risk factors for the pathogenesis and prognosis of patients with sepsis-associated coagulopathy[J]. Chinese Journal of General Practice, 2021, 19(12): 2020-2023. doi: 10.16766/j.cnki.issn.1674-4152.002225
|
| [3] |
LIU C, ZOU Q, TANG H X, et al. Melanin nanoparticles alleviate sepsis-induced myocardial injury by suppressing ferroptosis and inflammation[J]. Bioact Mater, 2022, 24: 313-321.
|
| [4] |
LIU H R, XU C Q, HU Q, et al. Sepsis-induced cardiomyopathy: understanding pathophysiology and clinical implications[J]. Arch Toxicol, 2024. DOI: 10.1007/s00204-024-03916-x.
|
| [5] |
HOLLENBERG S M, SINGER M. Pathophysiology of sepsis-induced cardiomyopathy[J]. Nat Rev Cardiol, 2021, 18(6): 424-434. doi: 10.1038/s41569-020-00492-2
|
| [6] |
TODOROVIC MARKOVIC M, TODOROVIC MITIC M, IGNJATOVIC A, et al. Mortality in community-acquired sepsis and infections in the Faroe Islands: a prospective observational study[J]. Infect Dis Rep, 2024, 16(3): 448-457. doi: 10.3390/idr16030033
|
| [7] |
JIANG T, WANG Q, LV J G, et al. Mitochondria-endoplasmic reticulum contacts in sepsis-induced myocardial dysfunction[J]. Front Cell Dev Biol, 2022, 10: 1036225. DOI: 10.3389/fcell.2022.1036225.
|
| [8] |
KUROSHIMA T, KAWAGUCHI S, OKADA M. Current perspectives of mitochondria in sepsis-induced cardiomyopathy[J]. Int J Mol Sci, 2024, 25(9): 4710. DOI: 10.3390/ijms25094710.
|
| [9] |
SRZIĆ I, NESEK ADAM V, TUNJIĆ PEJAK D. Sepsis definition: what's new in the treatment guidelines[J]. Acta Clin Croat, 2022, 61(Suppl 1): 67-72.
|
| [10] |
NASERI A, AKYUZ E, TURGUT K, et al. Sepsis-induced cardiomyopathy in animals: from experimental studies to echocardiography-based clinical research[J]. Can Vet J, 2023, 64(9): 871-877.
|
| [11] |
WU F, ZHANG Y T, TENG F, et al. S100a8/a9 contributes to sepsis-induced cardiomyopathy by activating ERK1/2-Drp1-mediated mitochondrial fission and respiratory dysfunction[J]. Int Immunopharmacol, 2023, 115: 109716. DOI: 10.1016/j.intimp.2023.109716.
|
| [12] |
张文静, 李晓峰, 孙明明, 等. 线粒体自噬在心肌梗死中的作用及研究进展[J]. 中华全科医学, 2022, 20(7): 1194-1198. doi: 10.16766/j.cnki.issn.1674-4152.002556
ZHANG W J, LI X F, SUN M M, et al. Research progress and function of mitophagy in myocardial infarction[J]. Chinese Journal of General Practice, 2022, 20(7): 1194-1198. doi: 10.16766/j.cnki.issn.1674-4152.002556
|
| [13] |
NI D, LIN X F, DENG C H, et al. Energy metabolism: from physiological changes to targets in sepsis-induced cardiomyopathy[J]. Hellenic J Cardiol, 2024, 80: 96-106. doi: 10.1016/j.hjc.2024.05.010
|
| [14] |
SONG J Y, FANG X L, ZHOU K X, et al. Sepsis-induced cardiac dysfunction and pathogenetic mechanisms (review)[J]. Mol Med Rep, 2023, 28(6): 227. DOI: 10.3892/mmr.2023.13114.
|
| [15] |
CHEN T T, YE L, ZHU J, et al. Inhibition of pyruvate dehydrogenase kinase 4 attenuates myocardial and mitochondrial injury in sepsis-induced cardiomyopathy[J]. J Infect Dis, 2024, 229(4): 1178-1188. doi: 10.1093/infdis/jiad365
|
| [16] |
韩永燕, 杨俊礼, 孟会敏, 等. 血尿素氮/白蛋白比值联合可溶性生长刺激表达基因2蛋白对急诊重症监护病房老年脓毒症患者心肌损伤的预警价值[J]. 中华老年医学杂志, 2024, 43(6): 727-732.
HAN Y Y, YANG J L, MENG H M, et al. Early warning value of blood urea nitrogen to albumin ratio combined with soluble growth stimulation expressed gene 2 on sepsis-induced myocardial injury in elderly patients in emergency intensive care unit[J]. Chinese Journal of Geriatrics, 2024, 43(6): 727-732.
|
| [17] |
SINGAM A. Myocardial injury as a harbinger of multi-organ failure in septic shock: a comprehensive review[J]. Cureus, 2024, 16(2): e55021. DOI: 10.7759/cureus.55021.
|
| [18] |
BLIXT P J, NGUYEN M, CHOLLEY B, et al. Association between left ventricular systolic function parameters and myocardial injury, organ failure and mortality in patients with septic shock[J]. Ann Intensive Care, 2024, 14(1): 12. DOI: 10.1186/s13613-023-01235-5.
|
| [19] |
陆珏秀, 刘先霞, 闫霖. 左室射血分数在急性心肌梗死中应用的研究进展[J]. 临床医学进展, 2023, 13(2): 1203-1208.
LU J X, LIU X X, YAN L. Research progress of left ventricular ejection fraction in acute myocardial infarction[J]. Advances in Clinical Medicine, 2023, 13(2): 1203-1208.
|
| [20] |
DE NUNZIO C, GHAHHARI J, LOMBARDO R, et al. Development of a nomogram predicting the probability of stone free rate in patients with ureteral stones eligible for semi-rigid primary laser uretero-litothripsy[J]. World J Urol, 2021, 39(11): 4267-4274. doi: 10.1007/s00345-021-03768-5
|